Day: October 6, 2020

With the new contract, PRA will assist Biomedical Advanced Research and Development Authority (BARDA) in the development of medical countermeasures for public healthRALEIGH, N.C., Oct. 06, 2020 (GLOBE NEWSWIRE) — PRA Health Sciences, Inc. (NASDAQ: PRAH) announced today it has been selected by the Biomedical Advanced Research and Development Authority (BARDA) to be a member of its updated Clinical Studies Network (CSN). Under a Clinical Trial Planning and Execution (CTPE) contract award, PRA will serve as a valued partner that provides clinical research services to develop medical countermeasures (MCMs) that protect health and save lives in public health emergencies.“This program represents important research that is necessary to protect and facilitate public health,” said Michael Massaro, Senior Vice President, Project Delivery...

TORONTO, Oct. 06, 2020 (GLOBE NEWSWIRE) — Colliers International Group Inc. (NASDAQ and TSX: CIGI), announced today that results for the third quarter ended September 30, 2020 will be issued by press release on Tuesday, October 27, 2020, at approximately 7:00am ET.The conference call to review these financial results will take place at 11:00am ET on Tuesday, October 27, 2020, and will be hosted by Jay S. Hennick, Chairman & CEO, John Friedrichsen, COO and Christian Mayer, CFO. The numbers to use for this call are: 1) toll-free 1-877-402-8911; or 2) for international callers 1-707-927-4894, with the conference ID number 6475418 for all participants.The conference call will also be accessible at Corporate.Colliers.com in the “Events” section. For anyone unable to listen to the scheduled call, the rebroadcast number will be 1-855-859-2056...

PRINCETON, N.J., Oct. 06, 2020 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today certain unaudited preliminary third quarter financial results. The company also announced that it will release full third quarter 2020 financial results on Wednesday, October 28, 2020 at 8:30 a.m. ET.Preliminary Third Quarter Revenue ResultsThird quarter 2020 reported revenue is expected to be in the range of $368 million to $370 million, representing a decline of approximately 2.7% on a reported basis and approximately 1.8% on an organic basis compared to the third quarter of 2019.These results exceeded the Company’s third quarter revenue outlook range provided in August during the second quarter conference call and represent a significant recovery from the second...

Steven H. Rouhandeh Appointed as Chairman of the Board of DirectorsJefferies LLC Retained as Financial Advisor to Assist with the Review of Strategic OptionsNEW YORK and CLEVELAND, Oct. 06, 2020 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced that its Board of Directors has formed a Special Committee to oversee and advise the executive leadership team on the operations of the Company, leveraging the respective medical, business development and financial expertise of its members. The Special Committee, which consists of current board members, is also working closely with the executive leadership team to develop the Company’s strategic direction and leadership plan as it continues to advance its clinical programs toward providing novel gene and cell therapies...

LAS VEGAS and VANCOUVER, British Columbia, Oct. 06, 2020 (GLOBE NEWSWIRE) — TAAT LIFESTYLE & WELLNESS LTD. (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2) (the “Company” or “Taat”) is pleased to announce that Ohio-based ADCO Distributors, Inc. (“ADCO”), an established distributor of tobacco cigarettes for top global brands (e.g., Marlboro, Newport, Camel) has entered into a binding comprehensive distribution agreement with the Company (dated Tuesday October 6, 2020) to carry Taat in its Original, Smooth, and Menthol varieties among its tobacco cigarette offerings. With direct and indirect connections to more than 5,000 convenience points of sale in Ohio, where Taat is to be launched in mid-Q4 2020, ADCO is also a distributor in other major convenience categories to include confection, snacks, and beverages. At the time of this...

CALGARY, Alberta, Oct. 06, 2020 (GLOBE NEWSWIRE) — Gibson Energy Inc. announced today it expects to release its 2020 third quarter financial and operating results on Monday, November 2, 2020 after the close of North American markets. The 2020 third quarter management’s discussion and analysis and unaudited consolidated financial statements will be available on the Company’s website at www.gibsonenergy.com and on SEDAR at www.sedar.com.Earnings Conference Call & Webcast DetailsA conference call and webcast will be held to discuss the 2020 third quarter financial and operating results at 7:00am Mountain Time (9:00am Eastern Time) on Tuesday, November 3, 2020.The conference call dial-in numbers are:478-219-0003 / 844-358-6759Participant Pass Code: 4345718This call will also be broadcast live on the Internet and may...

THIS PRESS RELEASE IS NOT FOR DISTRIBUTION TO NEWS SERVICES FOR DISSEMINATION IN THE UNITED STATESMONTREAL, Oct. 06, 2020 (GLOBE NEWSWIRE) — The management of Vanstar Mining Resources Inc. (VSR-TSX-V) is very pleased to announce the first results from the sampling campaign on the Amanda project during the summer of 2020. A total of 576 samples were taken from the entire property consisting of 145 claims covering an area of ​​approximately 7,677 hectares. This sampling is the first field reconnaissance work carried out by Vanstar to verify areas of geological interest across the property and to confirm the gold potential identified by historical work. Several new showings were traced by this first geological survey, demonstrating an interesting gold environment for the entire Amanda project.The Raphy showing returned grades of 1.21...

CE COMMUNIQUÉ DE PRESSE N’EST PAS POUR DISTRIBUTION AUX SERVICES DE NOUVELLES POUR DIFFUSION AUX ÉTATS-UNISMONTRÉAL, 06 oct. 2020 (GLOBE NEWSWIRE) — La direction de Ressources Minières Vanstar Inc ( VSR-TSX-V ) est très heureuse d’annoncer les premiers résultats provenant de la campagne d’échantillonnage sur le projet Amanda à l’été 2020. Un total de 576 échantillons a été prélevé sur l’ensemble de la propriété. Ces travaux d’échantillonnage constituent les premiers travaux de reconnaissance de terrain réalisés par Vanstar en vue de vérifier les zones d’intérêt géologique sur l’ensemble de la propriété et de confirmer le potentiel aurifère identifié dans les travaux historiques.L’indice Raphy a donné des teneurs de 1,21 et 1,26 g/t Au (F50337 et F50338) dans des paragneiss à biotite silicifiés et minéralisés en pyrite. Sept...

NEWARK, Del., Oct. 06, 2020 (GLOBE NEWSWIRE) — Artesian Water Company announced today that the Chesapeake Section of the American Water Works Association (AWWA) has awarded their Operator of the Year Award to Jeff Price, Manager of Artesian’s Southern Delaware Water Operations. This award is given “based upon Health Department standards for excellence in operation and maintenance” according to the Chesapeake Section of the AWWA.Mr. Price has been a certified licensed water operator by the State of Delaware for over 25 years. In his current position, Mr. Price currently oversees 21 treatment plants that provide water to over 35,000 customers. Under Jeff’s leadership Artesian’s Southern Delaware Water Operations department has expanded from South Bethany to Selbyville, Frankford, and Dagsboro, one of the fastest growing areas in Delaware....

Conference Call and Webcast Scheduled for October 13, 2020, 4:30 pm ETNEW YORK, NY, Oct. 06, 2020 (GLOBE NEWSWIRE) — Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostics company, announced today that it will report fourth quarter and fiscal year 2020 financial results on Tuesday, October 13, 2020, after the market close. The announcement will be followed by a live audio webcast and conference call at 4:30 pm Eastern Time.Tuesday, October 13th @ 4:30pm ETAbout Enzo Biochem Enzo Biochem is a pioneer in molecular diagnostics, leading the convergence of clinical laboratories, life sciences and intellectual property through the development of unique diagnostic platform technologies that provide numerous advantages over previous standards. A global company, Enzo Biochem utilizes cross-functional teams to develop and deploy...